ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc (VRPX)

0,169
0,0025
(1,50%)
Geschlossen 17 März 9:00PM
0,124
-0,045
( -26,63% )
Vor Marktöffnung: 11:44AM
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,124
Gebot
0,1242
Fragen
0,126
Volumen
210.011
0,00 Tagesbereich 0,00
0,1213 52-Wochen-Bereich 4,825
Marktkapitalisierung
Handelsende
0,169
Handelsbeginn
-
Letzter Handelszeitpunkt
11:33:19
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.819.746
Ausgegebene Aktien
26.562.581
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,37
Gewinn pro Aktie (EPS)
-0,45
Erlöse
-
Nettogewinn
-12,07M

Über Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Virpax Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRPX. The last closing price for Virpax Pharmaceuticals was US$0,17. Over the last year, Virpax Pharmaceuticals shares have traded in a share price range of US$ 0,1213 to US$ 4,825.

Virpax Pharmaceuticals currently has 26.562.581 shares in issue. The market capitalisation of Virpax Pharmaceuticals is US$4,49 million. Virpax Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.37.

VRPX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0648-34.32203389830.18880.18880.121311486810.17390055CS
4-0.1644-57.00416088770.28840.33320.121369978670.23431456CS
12-0.207-62.53776435050.3310.5150.121358197460.28590258CS
26-0.64-83.76963350790.7641.050.121343036050.38950475CS
52-3.836-96.86868686873.964.8250.121336576630.81336478CS
156-20.176-99.389162561620.3250.121312737401.20560498CS
260-79.876-99.84580359.7990.1213142285639.14193121CS

VRPX - Frequently Asked Questions (FAQ)

What is the current Virpax Pharmaceuticals share price?
The current share price of Virpax Pharmaceuticals is US$ 0,124
How many Virpax Pharmaceuticals shares are in issue?
Virpax Pharmaceuticals has 26.562.581 shares in issue
What is the market cap of Virpax Pharmaceuticals?
The market capitalisation of Virpax Pharmaceuticals is USD 4,49M
What is the 1 year trading range for Virpax Pharmaceuticals share price?
Virpax Pharmaceuticals has traded in the range of US$ 0,1213 to US$ 4,825 during the past year
What is the PE ratio of Virpax Pharmaceuticals?
The price to earnings ratio of Virpax Pharmaceuticals is -0,37
What is the reporting currency for Virpax Pharmaceuticals?
Virpax Pharmaceuticals reports financial results in USD
What is the latest annual profit for Virpax Pharmaceuticals?
The latest annual profit of Virpax Pharmaceuticals is USD -12,07M
What is the registered address of Virpax Pharmaceuticals?
The registered address for Virpax Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Virpax Pharmaceuticals website address?
The website address for Virpax Pharmaceuticals is www.virpaxpharma.com
Which industry sector does Virpax Pharmaceuticals operate in?
Virpax Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AFRIForafric Global PLC
US$ 13,69
(59,93%)
13
KTCCKeyTronic Corporation
US$ 4,26
(59,55%)
221
LGHLWLion Group Holding Ltd
US$ 0,01
(58,73%)
1
LEELee Enterprises Inc
US$ 12,99
(51,22%)
145
RGCRegencell Bioscience Holdings Ltd
US$ 27,74
(49,95%)
184,48k
ATXIAvenue Therapeutics Inc
US$ 0,5249
(-38,40%)
69,96k
HYPRHyperfine Inc
US$ 0,9352
(-26,94%)
504,79k
AGMHAGM Group Holdings Inc
US$ 0,0772
(-26,89%)
3,83M
VRPXVirpax Pharmaceuticals Inc
US$ 0,124
(-26,63%)
210,01k
ANTEAirNet Technology Inc
US$ 1,21
(-24,84%)
369,65k
GNPXGenprex Inc
US$ 0,4771
(19,28%)
15,79M
BONBon Natural Life Ltd
US$ 0,7038
(14,89%)
15,19M
SYRSSyros Pharmaceuticals Inc
US$ 0,1286
(49,88%)
12,13M
PIIIP3 Partners Inc
US$ 0,1603
(-6,42%)
5M
SHViShares Short Treasury Bond ETF
US$ 110,30
(0,01%)
4,65M

VRPX Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen